CAFs in EAC: They have a key role in secreting several growth factors such as VEGF and TGF-β, which promote the development of an immunosuppressive niche, and enhanced tumor invasiveness (MMP-3–mediated ECM modification via E-cadherin degradation) and drug resistance. The gene discussed is VEGFA; the disease is neoplasm.